Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V, Sørensen FB, Bentzen SM, Ladekarl M, Nielsen OS, Keller J, Jensen OM. Jensen V, et al. Among authors: ladekarl m. Histopathology. 1998 Jun;32(6):536-46. Histopathology. 1998. PMID: 9675593
Feasibility and early clinical impact of precision medicine for late-stage cancer patients in a regional public academic hospital.
Ladekarl M, Nøhr AK, Sønderkær M, Dahl SC, Sunde L, Vestereghem C, Mapendano CK, Haslund CA, Pagh A, Carus A, Lörincz T, Nowicka-Matus K, Poulsen LØ, Laursen RJ, Dybkær K, Poulsen BK, Frøkjær JB, Brügmann AH, Ernst A, Wanders A, Bøgsted M, Pedersen IS. Ladekarl M, et al. Acta Oncol. 2023 Mar;62(3):261-271. doi: 10.1080/0284186X.2023.2185542. Epub 2023 Mar 11. Acta Oncol. 2023. PMID: 36905645
A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01).
Rasmussen LS, Winther SB, Chen IM, Weber B, Ventzel L, Liposits G, Johansen JS, Detlefsen S, Egendal I, Shim S, Christensen S, Pfeiffer P, Ladekarl M. Rasmussen LS, et al. Among authors: ladekarl m. BMC Cancer. 2023 Jun 16;23(1):552. doi: 10.1186/s12885-023-11035-6. BMC Cancer. 2023. PMID: 37328835 Free PMC article. Clinical Trial.
ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial.
Kringelbach T, Højgaard M, Rohrberg K, Spanggaard I, Laursen BE, Ladekarl M, Haslund CA, Harsløf L, Belcaid L, Gehl J, Søndergaard L, Eefsen RL, Hansen KH, Kodahl AR, Jensen LH, Holt MI, Oellegaard TH, Yde CW, Ahlborn LB, Lassen U. Kringelbach T, et al. Among authors: ladekarl m. BMC Cancer. 2023 Feb 22;23(1):182. doi: 10.1186/s12885-023-10632-9. BMC Cancer. 2023. PMID: 36814246 Free PMC article. Clinical Trial.
Scrotal Paget's Disease Associated With Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Apocrine Carcinoma With Complete Response to Paclitaxel, Trastuzumab, and Pertuzumab.
Nowicka-Matus K, Salkus G, Sønderkær M, Søkilde Pedersen I, Ernst A, Kubik M, Takacs-Szabo Z, Ladekarl M. Nowicka-Matus K, et al. Among authors: ladekarl m. JCO Precis Oncol. 2023 Aug;7:e2300173. doi: 10.1200/PO.23.00173. JCO Precis Oncol. 2023. PMID: 37595182 No abstract available.
88 results